Citigroup’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1K | Sell |
11,772
-16,374
| -58% | -$23.7K | ﹤0.01% | 4381 |
|
|
2025
Q1 | $38.8K | Sell |
28,146
-12,097
| -30% | -$16.7K | ﹤0.01% | 4178 |
|
|
2024
Q4 | $122K | Buy |
40,243
+12,450
| +45% | +$37.8K | ﹤0.01% | 3894 |
|
|
2024
Q3 | $138K | Buy |
27,793
+19,347
| +229% | +$96.3K | ﹤0.01% | 3835 |
|
|
2024
Q2 | $49.4K | Sell |
8,446
-108,475
| -93% | -$635K | ﹤0.01% | 3854 |
|
|
2024
Q1 | $928K | Buy |
116,921
+43,758
| +60% | +$347K | ﹤0.01% | 2424 |
|
|
2023
Q4 | $427K | Buy |
+73,163
| New | +$427K | ﹤0.01% | 2800 |
|